These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 27583669)
21. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details. Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782 [TBL] [Abstract][Full Text] [Related]
22. The airway microbiota in early cystic fibrosis lung disease. Frayman KB; Armstrong DS; Grimwood K; Ranganathan SC Pediatr Pulmonol; 2017 Nov; 52(11):1384-1404. PubMed ID: 28815937 [TBL] [Abstract][Full Text] [Related]
23. Is the type of chronic pulmonary infection a determinant of lung function outcomes in adult patients with cystic fibrosis? Lopes AJ; Mafort TT; de Sá Ferreira A; Santos de Castro MC; Cássia de Firmida M; de Andrade Marques E Monaldi Arch Chest Dis; 2012; 77(3-4):122-8. PubMed ID: 23461248 [TBL] [Abstract][Full Text] [Related]
24. Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease. Cribbs SK; Beck JM Transl Res; 2017 Jan; 179():84-96. PubMed ID: 27559681 [TBL] [Abstract][Full Text] [Related]
25. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation. Bonvillain RW; Valentine VG; Lombard G; LaPlace S; Dhillon G; Wang G J Heart Lung Transplant; 2007 Sep; 26(9):890-7. PubMed ID: 17845927 [TBL] [Abstract][Full Text] [Related]
26. [The lung microbiome in 2015: a window on chronic lung diseases]. Andréjak C; Delhaes L Med Sci (Paris); 2015 Nov; 31(11):971-8. PubMed ID: 26576604 [TBL] [Abstract][Full Text] [Related]
27. Pathogenesis could be one of the anti-cheating mechanisms for Pseudomonas aeruginosa society. Huang Z; Jiang Y; Liang J Med Hypotheses; 2011 Feb; 76(2):166-8. PubMed ID: 20934258 [TBL] [Abstract][Full Text] [Related]
28. Host-pathogen interplay in the respiratory environment of cystic fibrosis. Yonker LM; Cigana C; Hurley BP; Bragonzi A J Cyst Fibros; 2015 Jul; 14(4):431-439. PubMed ID: 25800687 [TBL] [Abstract][Full Text] [Related]
29. Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis. Sherrard LJ; Tunney MM; Elborn JS Lancet; 2014 Aug; 384(9944):703-13. PubMed ID: 25152272 [TBL] [Abstract][Full Text] [Related]
30. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy. Levy J Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160 [TBL] [Abstract][Full Text] [Related]
31. Clinical Insights into Pulmonary Exacerbations in Cystic Fibrosis from the Microbiome. What Are We Missing? Whelan FJ; Surette MG Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S207-11. PubMed ID: 26595741 [TBL] [Abstract][Full Text] [Related]
33. The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis. Amin R; Lam M; Dupuis A; Ratjen F Pediatr Pulmonol; 2011 Jun; 46(6):554-8. PubMed ID: 21337727 [TBL] [Abstract][Full Text] [Related]